Figure 3From: Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients' survival when delivered as usual care Unadjusted Kaplan-Meier cardiovascular (CV) survival curves according to the number of cardiovascular drug classes claimed during index period among survivors at 30 days who received a revascularization (n = 1123). * The curves are statistically different (p = 0.006)Back to article page